|
Oncology drug maker reports 74% increase in sales.
Publication: Drug Week Publication Date: 23-MAY-03 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 NewsRX
2003 MAY 23 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced that Thalomid (thalidomide) sales increased 74% for the quarter ended March 31, 2003, to $45.6 million from $26.2 million in the first quarter of 2002.
Total revenue was $49.1 million, rising 60% over the prior-year quarter. Celgene posted net income of $952,000...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Drug Week |
Ophthalmology company reports net earnings rose 38.5% in first quarter...
May 23, 2003
|
Pain medication company reports strong growth for Percocet, Lidoderm.
May 23, 2003
|
Pharmaceutical company reports earnings of $0.15 per share.
May 23, 2003
|
Pharmaceutical company reports third quarter earnings per share of $0....
May 23, 2003
|
Private placement offering of $3.24M completed by biotech investment c...
May 23, 2003
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
